Abstract:
Summary.
The clinical and laboratory properties of hemostasis disturbances the patients with different
variants of the lupus nephritis and the correction possibilities with antiagregants and anticoagulation
drugs we studied. The bleeding syndrome was found to 64,7% patients with lupus nephritis and in
17,6% cases this one were associated with the thrombotic syndrome. This results show the presence
of DIC syndrome in patients with lupus nephritis which is manifested with thrombohemorrhagic
syndrome and decreased antithrombin III activity. These date indicate the necessity of study
hemostasis system and the association of the antiagregants and anticoagulation drugs to the basis
treatement of the patients with lupus nephritis.
